Determining if your patient is a candidate for venom immunotherapy with whole allergen testing can be difficult as up to 59% of venom patients test positive for both bee and wasp venom.
That’s why Labcorp now offers component-resolved diagnostic testing to discriminate between true sensitization and cross-reactivity, improving specificity and:
While venom allergy testing can confirm a diagnosis, it cannot itself make a diagnosis nor reliably predict the severity of a reaction. Test results can guide the selection of venom immunotherapy (VIT).3,4
Patients with a large local sting reaction or those with a relative with a stinging insect allergy should not be tested.
People who have experienced an allergic reaction to an insect sting have a 60% chance of a similar or worse reaction if stung again.5